Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Tracon Pharma (TCON)

Tracon Pharma (TCON)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Tracon Pharma 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 USA

P: 858-550-0780 F: 858-550-0786

Description:

TRACON Pharmaceuticals, Inc. is a biopharmaceutical company. The company's product candidate includes TRC105, TRC205 and TRC102 which are in different clinical stage for cancer, age-related macular degeneration and fibrotic diseases. TRACON Pharmaceuticals, Inc. is headquartered in San Diego, California.

Key Statistics

Overview:

Market Capitalization, $K 40,099
Shares Outstanding, K 20,252
Annual Sales, $ 350 K
Annual Net Income, $ -28,670 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -9,470 K
60-Month Beta 1.60
% of Insider Shareholders 23.30%
% of Institutional Shareholders 51.35%
Float, K 15,533
% Float 76.70%
Short Volume Ratio 0.44

Growth:

1-Year Return -70.23%
3-Year Return -68.03%
5-Year Return -91.00%
5-Year Revenue Growth -89.86%
5-Year Earnings Growth 92.21%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.48 on 05/11/22
Next Earnings Date 08/10/22
Earnings Per Share ttm -1.84
EPS Growth vs. Prev Qtr -20.00%
EPS Growth vs. Prev Year -45.45%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 11/08/19

TCON Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -292.18%
Return-on-Assets % -125.97%
Profit Margin % -8,191.43
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 117.06
Price/Cash Flow N/A
Price/Book 14.39
Book Value/Share 0.14
Interest Coverage -88.59
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar